Research suggests that mullein, among other botanical compounds, may offer potential support for respiratory health, particularly in the context of viral respiratory infections such as colds, influenza, and coronavirus-related illnesses. The available evidence comes primarily from a 2022 narrative review examining plant-derived compounds broadly, rather than from clinical trials or randomized controlled studies focused specifically on mullein, which represents a meaningful limitation in drawing firm conclusions. Studies indicate that while certain botanicals show promise by targeting various mechanisms involved in respiratory viral activity, the specific active compounds in mullein and precisely how they might work remain areas requiring further investigation. Overall, the research base is preliminary and exploratory in nature, and more targeted clinical research would be needed before strong conclusions can be drawn about mullein's effectiveness for respiratory health.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Plant-Based Support of Respiratory Health during Viral Outbreaks. | Other | 2022 | Supports | 100 |